<DOC>
	<DOCNO>NCT03077191</DOCNO>
	<brief_summary>This homogeneous , single institution , observational , non -interventional , prospective study 500 patient treat accord standard protocol adjuvant hypofractionated radiotherapy breast conserving surgery , forward-planned intensity- modulate radiation therapy ( IMRT ) total dose 40 Gy/ 15 fr ( 5 fr/ week , 3 consecutive week ) . In addition regular follow , patient respond quality life questionnaire ( QLQ ) European Organisation Research Treatment Cancer ( EORTC ) , general , QLQ- C30 , specific breast ( BR ) , QLQ- BR23 , first visit , end radiotherapy ant subsequent follow-up visit form 6 month 5 year half , evaluate quality life treatment . The study also retrospective arm , evaluation disease control toxicity result approximately 1300 patient treat January 2009 , hypofractionated radiotherapy adopt standard breast conserving radiotherapy , 2016 .</brief_summary>
	<brief_title>Toxicity Outcome Whole Breast Hypofractionated Radiotherapy : Single Institution Experience</brief_title>
	<detailed_description>The study observational , homogeneous ( perform single institution ) , non-interventional , two part : one retrospective one prospective ( ask registration register clinical trial ) . The patient breast cancer treat adjuvant hypofractionated radiotherapy Department Radiotherapy `` San Raffaele Scientific Institute '' ( IRCCSSRaffaele ) January 2009 June 2016 identify clinical dosimetric data retrieve analyzed . The objective retrospective arm study analysis follow 5 year acute late toxicity , clinical outcome , local regional control , overall survival , disease free survival , cancer-specific survival . A secondary objective identification prognostic factor toxicity disease progression . The objective prospective arm study , number 500 consecutive patient agree participate study , ass quality life patient treat hypofractionated short course ( 3 week ) radiotherapy . The quality life questionnaire ( QLQ ) European organization research treatment cancer ( EORTC ) , general , QLQ-C30 , specific breast ( BR ) , QLQ-BR23 , distribute radiation treatment , enrollment patient , end therapy follow visit , duration 5 year first follow , schedule 6 month yearly . Being observational non-interventional study , follow program patient breast cancer , treat accord standard departmental protocol , modify . The patient identify patient data base , medical record retrieve archive radiotherapy , alternatively electronic archive , picture monitorising local evolution photo archive . The data extract medical record . In addition , dosimetric data treatment recover physical dosimetric Archives extrapolate data related clinical toxicity outcome . For patient prospective observational arm , dosimetric data quality life questionnaire , asa well result follow visit prospectively collect register data base , subsequently analyze . The toxicity register visit carry treatment determine use Radiation Therapy Oncology Group ( RTOG ) scale , follow visit use Scoring system late effect radiation normal tissue ( SOMA-LENT scale ) . The clinical point analyze : quality life , overall survival , disease free- , cancer specific-survival , local regional control , distant metastasis free survival , acute late toxicity , physical dosimetry aesthetic result . The detected parameter correlate , identification prognostic factor . Statistical analyzes perform SPSS software version 17.0 ( SPSS Inc . Released 2008 . SPSS Statistic Windows , Version 17.0 . Chicago , USA : SPSS Inc. ) MedCalc v.12.1.4.0 ( MedCalc Software , Ostend , Belgium ) update version . Statistical test use : uni multivariate logistic regression define predictor incidence prevalence toxicity local/ distant relapse ; Cox model ( proportionally-hazard regression ) uni- multi-variate actuarial analysis predictor toxicity local/ distant relapse ; Wilcoxon match -pair test quality life index variation ; Spearman test correlation continuous variable , ANOVA test effect treatment variable change QoL scors time .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<criteria>Breast cancer patient TNM Classification Malignant Tumours pathological stage T1T2 , N0N1a ( pathologically node negative three positive lymphnodes ) , treat conservative surgery whole breast hypofractionated radiotherapy without boost male breast cancer patient breast cancer patient treat conservative surgery partial breast irradiation , relapse , treat adjuvant whole breast radiotherapy salvage conservative surgery breast cancer patient treat mastectomy patient TNM pathologic stage N1a treat whole breast radiotherapy supraclavicular fossa +/ axillary radiotherapy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>hypofractionated whole breast radiotherapy</keyword>
	<keyword>breast cancer</keyword>
	<keyword>conservative treatment</keyword>
	<keyword>quality life</keyword>
</DOC>